Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Other(3)

Detailed Status

unknown3
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%

Trials by Status

unknown375%
completed125%

Recent Activity

0 active trials
Showing 4 of 4
unknown

The Role of HRM and Specific Biomarkers of Inflammation in the Diagnosis of Patients With Dysphagia and Suspected EoE

NCT04803162
unknown

New Markers for Diagnosis of Prosthetic Infections

NCT03769337
completed

Brain Integrity in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation

NCT01820117
unknown

PET/CT for the Quantification of Atherosclerotic Plaque Inflammation

NCT01553513

Clinical Trials (4)

Showing 4 of 4 trials
NCT04803162

The Role of HRM and Specific Biomarkers of Inflammation in the Diagnosis of Patients With Dysphagia and Suspected EoE

Unknown
NCT03769337

New Markers for Diagnosis of Prosthetic Infections

Unknown
NCT01820117

Brain Integrity in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation

Completed
NCT01553513

PET/CT for the Quantification of Atherosclerotic Plaque Inflammation

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4